Ionis Pharmaceuticals competitorsClear all

Ionis Pharmaceuticals's top competitors include Arrowhead Pharmaceuticals, Alnylam Pharmaceuticals, Regulus Therapeutics and Inositec.

Save Comparison	Ionis Pharmaceuticals Ionis Pharmaceuticals discovers and develops RNA-targeted therapeutics.	Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.	Alnylam Pharmaceuticals Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.	Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.	Inositec Inositec is a company developing treatments for soft tissue calcification disorders.
Founding Date	Founding Date 1989	Founding Date 2004	Founding Date 2002	Founding Date 2007	Founding Date 2015
Type	Type Public	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development platform	Tags Healthcare biotech drug development genetics life sciences	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development platform
Locations	Locations Carlsbad, US HQ	Locations Pasadena, US HQ Madison, US	Locations Cambridge, US HQ Paris, FR Milano, IT Amsterdam, NL Stockholm, SE Zug, CH Maidenhead, GB	Locations San Diego, US HQ	Locations Zürich, CH HQ
Employees	Employees 81711% increase	Employees 13416% increase	Employees 1,32324% increase	Employees 2462% decrease	Employees 6
Valuation ($)	Valuation ($) 7.1 b	Valuation ($) 7 b	Valuation ($) 14.4 b	Valuation ($) 23.5 m	Valuation ($) N/A
Twitter followers	Twitter followers 3 k	Twitter followers 2.4 k	Twitter followers 13.4 k	Twitter followers 783	Twitter followers 46
Number of tweets (last 30 days)	Number of tweets (last 30 days) 27	Number of tweets (last 30 days) 13	Number of tweets (last 30 days) 41	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) N/A
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 7.7	Average likes per tweet (last 30 days) 35.4	Average likes per tweet (last 30 days) 8	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) N/A
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) N/A
Alexa Website Rank	Alexa Website Rank 259972	Alexa Website Rank 235448	Alexa Website Rank 294228	Alexa Website Rank 269443	Alexa Website Rank N/A
Employee Rating	Employee Rating 3.3	Employee Rating N/A	Employee Rating 4	Employee Rating 3	Employee Rating N/A
Financial
Revenue (est.)	Revenue (est.) $1.1b (FY, 2019)	Revenue (est.) $168.8m (FY, 2019)	Revenue (est.) $219.8m (FY, 2019)	Revenue (est.) $6.8m (FY, 2019)	Revenue (est.) N/A
Cost of goods	Cost of goods $4.4m (FY, 2019)	Cost of goods N/A	Cost of goods $25.1m (FY, 2019)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $1.1b (FY, 2019)	Gross profit N/A	Gross profit $194.7m (FY, 2019)	Gross profit N/A	Gross profit N/A
Net income	Net income $294.1m (FY, 2019)	Net income $68m (FY, 2019)	Net income ($886.1m) (FY, 2019)	Net income ($18.6m) (FY, 2019)	Net income N/A
Operating ⚠
Patents Issued	Patents Issued N/A	Patents Issued 359 (FY, 2016)	Patents Issued N/A	Patents Issued 300 (FY, 2016)	Patents Issued N/A
Funding
Total funding raised	Total funding raised $ 201.3m	Total funding raised $ 147.1m	Total funding raised $ 1.5b	Total funding raised $ 10m	Total funding raised N/A